Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbhfiledCriticalMerck Patent Gmbh
Priority to MYUI89000924ApriorityCriticalpatent/MY107599A/en
Publication of MY107599ApublicationCriticalpatent/MY107599A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
PHARMACEUTICAL FORMULATIONS IN THE FORM OF SUSPENSIONS CONTAINING SUCRALFATE, WHICH PREFERABLY CONSTITUTES 1 TO 40% BY WEIGHT OF THE FORMATION, CHARACTERISED IN THAT THEY CONTAIN, BASED ON THE SUCRALFATE, 1-5% BY WEIGHT OF XANTHAN GUM AND 1-12.5% BY WEIGHT OF AT LEAST ONE PEPTISER, WHICH IS PREFERABLY A SALT OF PHOSPHORIC ACID AND/OR CITRIC ACID.
Fungicides comprising triazolyl- or imidazolyl-group-substituted 2,5-dihydrofuran derivatives as active ingredient and process for producing the active ingredient and intermediaries thereof
Insecticides and acaricides containing as active substance derivatives of 2,2 difluor cycloprophil ethan and process for production of the active substance
Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter
NOVEL PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8 PHENYL-10 ANTHRONE-9 AS ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE ACTIVE INGREDIENT